Corbus Pharmaceuticals announces proposed public offering to fund clinical pipeline

5 hours ago 1

Corbus Pharmaceuticals (CRBP) plans an underwritten public offering of common stock and/or pre-funded warrants.
All securities in the offering will be sold by the company.
Proceeds will be used to advance clinical development of Corbus’s oncology and obesity pipeline, and for